Related content

NK cells dysfunction in systemic lupus erythematosus: relation to disease activity

By Henriques Ana  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 805-813

Springer Publishing Company

Access to resources Recommend Favorite

Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus

By Bello Kayode   Fang Hong   Fazeli Parastoo   Bolad Waleed   Corretti Mary   Magder Laurence   Petri Michelle  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2789-2796

Springer Publishing Company

Access to resources Recommend Favorite

Disease activity and antinucleosome antibodies in systemic lupus erythematosus

By Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 1, 2003-01 ,pp. : 42-45

Informa Healthcare

Access to resources Recommend Favorite

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease

By Hua X.   Su J.   Svenungsson E.   Hurt-Camejo E.   Jensen-Urstad K.   Angelin B.   Båvenholm P.   Frostegård J.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 3, 2009-01 ,pp. : 184-189

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients

By Paran D.   Fireman E.   Levartovsky D.   Elkayam O.   Kaufman I.   Litinsky I.   Caspi D.   Koifman B.   Keren G.   Schwarz Y.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 4, 2007-01 ,pp. : 285-290

Informa Healthcare

Access to resources Recommend Favorite